- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- Analysis
- Focus Articles
- Related Articles3 new
- Instablogs
- StockTalks1 new
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
AZN Market Currents
more »
-
May 15 Amylin (AMLN) has apparently attracted interest from potential suitors including Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers (BMY) and Sanofi (SNY), all of which have signed confidentiality agreements on the drugmaker's sale process. Sources say first-round bids are due in the next two weeks.
2 Comments[M&A, Healthcare]
AZN in Focus
more »
AZN Related Articles
more »
AZN News
more »
-
at CNBC.com (May 9, 2012)
-
at CNBC.com (May 8, 2012)
-
at MarketWatch.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 26, 2012)
AZN Press Releases and Filings
more »
-
Business Wire (May 10, 2012)
-
Business Wire (May 1, 2012)
-
Business Wire (Apr 25, 2012)
-
Business Wire (Apr 12, 2012)
-
Business Wire (Mar 26, 2012)
AZN Latest Transcript
more »
AZN Cramer
more »
AZN Instablog posts
more »
AZN vs. ETF Alternatives
Company Description
Currently, there's no company description for AZN.